TCL Archive Letter to the Editors: Scientists, Media Shouldn’t Overstate “Breakthroughs” May 29, 1998
TCL Archive ODAC Nixes Abraxane for Adjuvant Breast Cancer, While Genasense Falls Victim to Its Randomized Trial. September 8, 2006